Cargando…
Lipodystrophy in HIV patients: its challenges and management approaches
HIV-associated lipodystrophy is a term used to describe a constellation of body composition (lipoatrophy and lipohypertrophy) and metabolic (dyslipidemia and insulin resistance) alterations that accompany highly active antiretroviral therapy. These changes, which resemble metabolic syndrome, have be...
Autores principales: | Singhania, Rohit, Kotler, Donald P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257972/ https://www.ncbi.nlm.nih.gov/pubmed/22267946 http://dx.doi.org/10.2147/HIV.S14562 |
Ejemplares similares
-
New and emerging agents in the management of lipodystrophy in HIV-infected patients
por: Bonnet, Eric
Publicado: (2010) -
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo, Roger
Publicado: (2011) -
Biochemical Manifestation of HIV Lipodystrophy Syndrome
por: Ihenetu, Kenneth, et al.
Publicado: (2012) -
Approach to Dyslipidemia, Lipodystrophy, and Cardiovascular Risk in Patients with HIV Infection
por: Troll, J. Gregory
Publicado: (2010) -
HIV/AIDS and lipodystrophy: Implications for clinical management in resource-limited settings
por: Finkelstein, Julia L, et al.
Publicado: (2015)